Julieta Grasselli

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

Julieta Grasselli, Elena Élez, Ginevra Caratù et al. · Annals of Oncology · 2017 · 194 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in <i>BRAF</i> -Mutant Colorectal Cancer

Daniele Oddo, Erin M. Sennott, Ludovic Barault et al. · Cancer Research · 2016 · 122 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso et al. · Journal of Clinical Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Impact of circulating tumor DNA mutant allele fraction on prognosis in <i>RAS</i>‐mutant metastatic colorectal cancer

Elena Élez, Chiara Chianese, Enrique Sanz‐García et al. · Molecular Oncology · 2019 · 57 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

Michael Schenker, Mauricio Burotto, Martin Eduardo Richardet et al. · Journal for ImmunoTherapy of Cancer · 2024 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17